Merck Pharmaceuticals COVID Pill Awaiting Approval

Pharmaceutical giant Merck asked  the FDA Monday to authorize its pill for treating COVID-19 in what would add an entirely new and easy-to-use weapon to the world’s arsenal against the pandemic. If cleared by the Food and Drug Administration, a decision that could come in a matter of weeks, it would be the first pill shown to treat the illness. All other FDA-backed treatments against COVID-19 require an IV or injection.